康弘药业2025年第三季度净利润同比增长7.71%

Core Insights - Kanghong Pharmaceutical reported a revenue of 1.17 billion yuan for Q3 2025, representing a year-on-year growth of 4.75% [2] - The net profit attributable to shareholders for Q3 2025 was 303 million yuan, showing a year-on-year increase of 7.71% [2] - For the first three quarters of 2025, the company achieved a total revenue of 3.624 billion yuan, which is a 6.23% increase compared to the same period last year [2] - The net profit attributable to shareholders for the first three quarters of 2025 reached 1.033 billion yuan, reflecting a year-on-year growth of 6.08% [2]